Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.

by Joel Raffel, Arie R Gafson, Samer Dahdaleh, Omar Malik, Brynmor Jones, Richard Nicholas
Published 2017-01-01

Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon?

by Mark Wilson, Cillian McNamara, Luke Dixon, Pritika Gaur, Dermot Mallon, Christopher Coughlan, Francesca Tona, Wajanat Jan, Brynmor Jones

Clinical and biochemical characteristics of patients presenting with pituitary apoplexy

by Ali Abbara, Sophie Clarke, Pei Chia Eng, James Milburn, Devavrata Joshi, Alexander N Comninos, Rozana Ramli, Amrish Mehta, Brynmor Jones, Florian Wernig, Ramesh Nair, Nigel Mendoza, Amir H Sam, Emma Hatfield, Karim Meeran, Waljit S Dhillo, Niamh M Martin
Published 2018-10-01